Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

被引:243
作者
Tan, KB
Harrop, J
Reddy, M
Young, P
Terrett, J
Emery, J
Moore, G
Truneh, A
机构
[1] SmithKline Beecham Pharmaceut, Dept Mol Immunol, King Of Prussia, PA 19406 USA
[2] SmithKline Beecham Pharmaceut, Dept Biotechnol, Harlow CM19 5AD, Essex, England
关键词
death domain; mapping; soluble receptor;
D O I
10.1016/S0378-1119(97)00509-X
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
A novel (TL1), a recently described (TL2) TNF-like, and three recently described TNF receptor-like (TR1, TR2, TR3) molecules were identified by searching a cDNA database. TL1 and TL2 are type-II membrane proteins. TR2 and TR3 are type-I membrane proteins whereas TR1 appears to be a secreted protein. TL1, TL2, TR2 and TR3 were expressed in hematopoietic cells, whereas TR1 was not. Northern blots hybridized with the cDNA probes revealed multiple forms of RNA as well as inducible expression of TL1, TL2, TR2 and TR3. TL2 and TR3, in particular, were highly induced in activated CD4(+) T cells. Radiation hybrid mapping localized TR1 and TL2 to 8q24 and 3q26, respectively, which are not near any known superfamily members. TL1 was mapped to 9q32, near CD30L (9q33) and TR2 and TR3 mapped to the region of chromosome 1 that contains the TNFR-II, 4-1BB, OX40 and CD30 gene cluster at 1p36. Only TR3 in this cluster possesses a death domain. Southern blot analysis revealed the presence of TL and TR genes in different mammalian species. TL2, TR1, TR2 and TR3 were recently described by others as TRAIL/Apo-2L, OPG, HVEM and DR3/WSL-1/Apo-3/TRAMP/LARD, respectively. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:35 / 46
页数:12
相关论文
共 36 条
  • [1] Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93
  • [2] TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY MEMBERS AND THEIR LIGANDS
    ARMITAGE, RJ
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) : 407 - 413
  • [3] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [4] AN EVOLUTIONARY AND FUNCTIONAL-APPROACH TO THE TNF RECEPTOR/LIGAND FAMILY
    BEUTLER, B
    VANHUFFEL, C
    [J]. MICROBIAL PATHOGENESIS AND IMMUNE RESPONSE, 1994, 730 : 118 - 133
  • [5] UNRAVELING FUNCTION IN THE TNF LIGAND AND RECEPTOR FAMILIES
    BEUTLER, B
    VANHUFFEL, C
    [J]. SCIENCE, 1994, 264 (5159) : 667 - 668
  • [6] TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)
    Bodmer, JL
    Burns, K
    Schneider, P
    Hofmann, K
    Steiner, V
    Thome, M
    Bornand, T
    Hahne, M
    Schroter, M
    Becker, K
    Wilson, A
    French, LE
    Browning, JL
    MacDonald, HR
    Tschopp, J
    [J]. IMMUNITY, 1997, 6 (01) : 79 - 88
  • [7] CASCINO I, 1995, J IMMUNOL, V154, P2706
  • [8] Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
    Chinnaiyan, AM
    ORourke, K
    Yu, GL
    Lyons, RH
    Garg, M
    Duan, DR
    Xing, L
    Gentz, R
    Ni, J
    Dixit, VM
    [J]. SCIENCE, 1996, 274 (5289) : 990 - 992
  • [9] CONTENDERS IN FASL/TNF DEATH SIGNALING
    CLEVELAND, JL
    IHLE, JN
    [J]. CELL, 1995, 81 (04) : 479 - 482
  • [10] A FAMILY OF LIGANDS FOR THE TNF RECEPTOR SUPERFAMILY
    COSMAN, D
    [J]. STEM CELLS, 1994, 12 (05) : 440 - 455